Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Best practice in therapeutic drug monitoring
Autore:
Gross, AS;
Indirizzi:
Royal N Shore Hosp, Dept Clin Pharmacol, St Leonards, NSW 2065, Australia Royal N Shore Hosp St Leonards NSW Australia 2065 ds, NSW 2065, Australia
Titolo Testata:
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
, volume: 52, anno: 2001, supplemento:, 1
pagine: 5S - 10S
SICI:
0306-5251(2001)52:<5S:BPITDM>2.0.ZU;2-1
Fonte:
ISI
Lingua:
ENG
Soggetto:
COST-EFFECTIVENESS; META-ANALYSIS; PHARMACOKINETICS;
Keywords:
therapeutic drug monitoring; therapeutic management; clinical interpretation;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Clinical Medicine
Life Sciences
Citazioni:
23
Recensione:
Indirizzi per estratti:
Indirizzo: Gross, AS Royal N Shore Hosp, Dept Clin Pharmacol, St Leonards, NSW 2065, Australia Royal N Shore Hosp St Leonards NSW Australia 2065 65, Australia
Citazione:
A.S. Gross, "Best practice in therapeutic drug monitoring", BR J CL PH, 52, 2001, pp. 5S-10S

Abstract

It is the goal of Therapeutic Drug Monitoring (TDM) to use drug concentrations to manage a patient's medication regimen and optimise outcome. Limitedresources require that drug assays should only be performed when they do contribute to patient management. For this to be the case a therapeutic drugmonitoring service has a far greater role than just therapeutic drug measuring. This article describes the roles and functions of a Best Practice TDMservice. The features which can and should be strived for in each step of the TDM process-the decision to request a drug level, the biological sample, the request, laboratory measurement, communication of results by the laboratory, clinical interpretation and therapeutic management-are discussed.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 30/03/20 alle ore 10:12:17